Multiple Etiologies of Tumor Hypoxia Require Multifaceted Solutions
Open Access
- 15 January 2007
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (2) , 375-377
- https://doi.org/10.1158/1078-0432.ccr-06-2629
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Glucocorticoids Modulate Tumor Radiation Response through a Decrease in Tumor Oxygen ConsumptionClinical Cancer Research, 2007
- Avascular necrosis of the bones: an overlooked complication of pulse steroid treatment of multiple sclerosisEuropean Journal of Neurology, 2006
- Glucocorticoids Suppress Tumor Angiogenesis and In vivo Growth of Prostate Cancer CellsClinical Cancer Research, 2006
- Distinct Role of Macrophages in Different Tumor MicroenvironmentsCancer Research, 2006
- Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain MetastasesJournal of Clinical Oncology, 2006
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Clinical studies of hypoxia modification in radiotherapySeminars in Radiation Oncology, 2004
- Endothelin-1 Is a Critical Mediator of Myogenic Tone in Tumor ArteriolesCancer Research, 2004
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- Modification of Tumour Response by Calcium Antagonists in the SCVII/St Tumour Implanted at Two Different SitesInternational Journal of Radiation Biology, 1989